Ophthalmic

FTC Releases Agenda for May 18 Workshop on Proposed Changes to the Eyeglass Rule

Retrieved on: 
Thursday, May 4, 2023
Contact, Consumer protection, Insurance, Method, Glasses, Contact lens, DC, Prescription, Blog, Ophthalmic, Federal Trade Commission, Patient, FTC, Webcast, News, Social media, Financial adviser, Health insurance, Dietary supplement

The Federal Trade Commission released the tentative agenda for its May 18 workshop in Washington, DC, which will examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.

Key Points: 
  • The Federal Trade Commission released the tentative agenda for its May 18 workshop in Washington, DC, which will examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.
  • The workshop, A Clear Look at the Eyeglass Rule, is free and open to the public, and pre-registration is not required.
  • This panel will consider the need for the Eyeglass Rule’s prescription release requirement in today’s marketplace.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.

Azura Ophthalmics to Present New Data on AZR-MD-001 in Meibomian Gland Dysfunction at American Society of Cataract and Refractive Surgery and Association for Research in Vision and Ophthalmology Annual Meetings

Retrieved on: 
Thursday, April 20, 2023
Health, Surgery, Clinical Trials, Pharmaceutical, Optical, Biotechnology, ARVO, CT, Refractive surgery, Meibomian gland dysfunction, Ophthalmic, ASCRS, American Society of Cataract and Refractive Surgery, Pain, Selenium, Patient, Irritation, Research, Cataract, Society, MGD, Safety, Pharmaceutical industry, Dietary supplement, Selenium disulfide, Azura, Ophthalmology

Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations featuring positive efficacy and safety data from a Phase 2b study of the company’s lead drug candidate, AZR-MD-001, in Meibomian Gland Dysfunction (MGD).

Key Points: 
  • Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple presentations featuring positive efficacy and safety data from a Phase 2b study of the company’s lead drug candidate, AZR-MD-001, in Meibomian Gland Dysfunction (MGD).
  • Data will be featured at the upcoming Annual Meetings for the Association for Research in Vision and Ophthalmology (ARVO), April 23-27 in New Orleans and the American Society of Cataract and Refractive Surgery (ASCRS), May 5-8 in San Diego.
  • “At Azura, we are addressing MGD in a completely new way and our mission is to bring relief to the countless patients who are burdened by it and associated ocular surface conditions,” said Marc Gleeson, Chief Executive Officer of Azura.
  • “AZR-MD-001 is the first investigational medicine to achieve a positive sign and symptom outcome for Meibomian Gland Dysfunction.

Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Retrieved on: 
Thursday, March 23, 2023
Education, Health, Technology, Audio, Video, Training, Optical, Honorable Mention, Senior, General counsel, Life, AEA, External, Webby Awards, Policy, Silver, The Lens, Ophthalmic, Certification, Anthem, Corporation, International Academy, International Academy of Digital Arts and Sciences, The Excellence in Diversity Awards, Science, Digital art, Entertainment, Film industry, Alcon

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards.

Key Points: 
  • Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards.
  • Launched in 2021 by The Webby Awards, The Anthem Award winners are selected by the International Academy of Digital Arts and Sciences.
  • The interactive compliance experience was developed by Alcon’s Legal and Compliance team along with Labyrinth Training – an innovative company that combines first rate storytelling with award-winning interactive design to bring corporate policies to life.
  • “We are honored to be recognized by The Anthem Awards for our company-wide compliance training program, The Lens,” said Royce Bedward, Senior Vice President, General Counsel and Corporate Secretary for Alcon.

FTC to Host Public Workshop on Proposed Changes to Its Ophthalmic Practice Rules, also Known as the Eyeglass Rule, in May in Washington, DC

Retrieved on: 
Tuesday, March 21, 2023
Consumer protection, Insurance, Register, Internet, Commission, Ophthalmology, Prescription, Glasses, Blog, Ophthalmic, Federal Trade Commission, Federal Register, Constitution Center (Washington, D.C.), Patient, FTC, News, Social media, Financial adviser, Health insurance

The Federal Trade Commission will host a public workshop on May 18, 2023, in Washington, DC, to examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.

Key Points: 
  • The Federal Trade Commission will host a public workshop on May 18, 2023, in Washington, DC, to examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.
  • The workshop, A Clear Look at the Eyeglass Rule, is free and open to the public, and pre-registration is not required.
  • Written comments related to agenda topics or issues discussed at the workshop must be received by June 20, 2023.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.

FTC to Host Public Workshop on Proposed Changes to Its Ophthalmic Practice Rules, also Known as the Eyeglass Rule, in May in Washington, DC

Retrieved on: 
Tuesday, March 21, 2023
Consumer protection, Insurance, Register, Internet, Commission, Ophthalmology, Prescription, Glasses, Blog, Ophthalmic, Federal Trade Commission, Federal Register, Constitution Center (Washington, D.C.), Patient, FTC, News, Social media, Financial adviser, Health insurance

The Federal Trade Commission will host a public workshop on May 18, 2023, in Washington, DC, to examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.

Key Points: 
  • The Federal Trade Commission will host a public workshop on May 18, 2023, in Washington, DC, to examine proposed changes to its Ophthalmic Practice Rules, also known as the Eyeglass Rule.
  • The workshop, A Clear Look at the Eyeglass Rule, is free and open to the public, and pre-registration is not required.
  • Written comments related to agenda topics or issues discussed at the workshop must be received by June 20, 2023.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.

FTC Sends Cease and Desist Letters to Prescribers Regarding Potential Violations of the Commission’s Contact Lens Rule

Retrieved on: 
Sunday, February 26, 2023
Glasses, Social media, Blog, News, Federal Trade Commission, Patient, FAQ, FTC, Contact, Contact lens, Sale, Ophthalmic, Consumer protection, Sellers, Dietary supplement, Generic drug

Federal Trade Commission staff sent 24 cease and desist letters to eye care prescribers after receiving complaints claiming that the prescribers failed to comply with the Contact Lens Rule.

Key Points: 
  • Federal Trade Commission staff sent 24 cease and desist letters to eye care prescribers after receiving complaints claiming that the prescribers failed to comply with the Contact Lens Rule.
  • Some letters also cited potential violations of the Ophthalmic Practice Rules (known as the Eyeglass Rule).
  • The letters warn the prescribers that violations of the Contact Lens Rule or Eyeglass Rule may result in legal action, including civil penalties of up to $50,120 per violation.
  • Along with the letters, staff also provided prescribers with links to its business guidance pieces, FAQs: Complying with the Contact Lens Rule and The Contact Lens Rule: A Guide for Prescribers and Sellers and, where appropriate, Complying with the Eyeglass Rule .

FTC Sends Cease and Desist Letters to Prescribers Regarding Potential Violations of the Commission’s Contact Lens Rule

Retrieved on: 
Sunday, February 26, 2023
Glasses, Social media, Blog, News, Federal Trade Commission, Patient, FAQ, FTC, Contact, Contact lens, Sale, Ophthalmic, Consumer protection, Sellers, Dietary supplement, Generic drug

Federal Trade Commission staff sent 24 cease and desist letters to eye care prescribers after receiving complaints claiming that the prescribers failed to comply with the Contact Lens Rule.

Key Points: 
  • Federal Trade Commission staff sent 24 cease and desist letters to eye care prescribers after receiving complaints claiming that the prescribers failed to comply with the Contact Lens Rule.
  • Some letters also cited potential violations of the Ophthalmic Practice Rules (known as the Eyeglass Rule).
  • The letters warn the prescribers that violations of the Contact Lens Rule or Eyeglass Rule may result in legal action, including civil penalties of up to $50,120 per violation.
  • Along with the letters, staff also provided prescribers with links to its business guidance pieces, FAQs: Complying with the Contact Lens Rule and The Contact Lens Rule: A Guide for Prescribers and Sellers and, where appropriate, Complying with the Eyeglass Rule .

Ophthalmic Lasers Market Report 2022: Technological Advancements in Glaucoma Management Present Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023
Medical Devices, Health, Hospital, GBP, News, Investment, Laser, Value, YAG laser, Customer support, COVID-19, Use, AUD, CHF, Market share analysis, AMD, Diabetic retinopathy, Weakness, Strategic management, Mergers and acquisitions, Growth, Application, Collaborative partnership, JPY, Refractive error, Research, Ophthalmic, Acquisition, CAD, USD, Laser ablation, Business Growth Fund, Cryptocurrency, 3D printing, Retail, EUR

This research report categorizes the Ophthalmic Lasers to forecast the revenues and analyze the trends in each of the following sub-markets:

Key Points: 
  • This research report categorizes the Ophthalmic Lasers to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Type, the market was studied across Photo Disruption Ophthalmic Lasers, Photocoagulating Ophthalmic Lasers, and SLT Ophthalmic Lasers.
  • Based on Product, the market was studied across Diode Lasers, Excimer Lasers, Femtosecond Lasers, and Nd: YAG Lasers.
  • What is the market share of the leading vendors in the Global Ophthalmic Lasers Market?
  • What modes and strategic moves are considered suitable for entering the Global Ophthalmic Lasers Market?

STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO

Retrieved on: 
Monday, December 19, 2022
Surgery, Medical Devices, Health, Optical, Medical Supplies, Surgeon, Security (finance), Bausch, Patient, U.S. FDA, Johnson & Johnson Vision, Surgery, Lens, Myopia, Ophthalmic, EVO, Eye, Freedom, Lens (anatomy), Growth, COVID-19, Marketing, Senior, FDA, Audit committee, ICL, Sustainability Accounting Standards Board, Multimedia, Abbott Laboratories, Chairperson, Laboratory, Lead, AMO, Physician, Poly Implant Prothèse, STAAR, Worldwide, Housing, Communities and Local Government Committee, Management, Risk management

STAAR’s Board of Directors has appointed ophthalmic industry executive Thomas “Tom” G. Frinzi, current Board Chair of STAAR, to serve as President and CEO, effective January 1, 2023.

Key Points: 
  • STAAR’s Board of Directors has appointed ophthalmic industry executive Thomas “Tom” G. Frinzi, current Board Chair of STAAR, to serve as President and CEO, effective January 1, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20221219005204/en/
    Ophthalmic industry executive Tom Frinzi has been appointed President & CEO of STAAR Surgical, effective January 1, 2023.
  • Prior to joining STAAR, Ms. Mason served as CEO and in other senior executive roles at numerous innovative healthcare, life sciences, diagnostic technology, and medical device companies.
  • “Serving as CEO of STAAR Surgical has been the highlight of my career,” said Ms. Mason.

FTC Proposes Updating Eyeglass Rule to Require Prescribers to Get Signed Confirmation When Providing a Prescription to Their Patients

Retrieved on: 
Friday, December 16, 2022
Consumer, Social media, Lens (anatomy), Contact lens, Consumer protection, Ophthalmic, Contact, Federal Register, Blog, Glasses, Patient, Federal Trade Commission, FTC, Prescription, Commission, News, Ophthalmology, Processor register, California Naloxone Requirement Bill, Insurance, Bureau, Health insurance, Pharmaceutical industry, Dietary supplement

To remedy that and enforce the law we are proposing that prescribers now get a signed confirmation when they release prescriptions to their patients.

Key Points: 
  • To remedy that and enforce the law we are proposing that prescribers now get a signed confirmation when they release prescriptions to their patients.
  • Under the rule, prescribers also cannot require that patients buy eyeglasses as a condition of providing them with a copy of their prescription, place a liability waiver on the prescription, require patients to sign a waiver, or require patients to pay an additional fee in exchange for a copy of their prescription.
  • Prescribers further cannot refuse to perform an eye exam unless the patient buys eyeglasses, contact lenses, or other ophthalmic goods from them.
  • Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.